Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Oct 9 2024

Full Issue

Medicare To Announce Pilot Program That Offers Some Generic Drugs For $2

Axios reports the Biden administration today will release a preliminary list of generic drugs for Medicare recipients that would cost no more than $2 out of pocket. The pilot program aims to test drug adherence and health outcomes.

The Biden administration on Wednesday will release a preliminary list of generic drugs that would be made available to Medicare recipients under a pilot program for no more than $2 out of pocket. The initiative — which covers common drugs for high cholesterol, high blood pressure and other chronic conditions — aims to test whether offering low-cost generics can boost seniors' medication adherence and health outcomes, while giving them more certainty on out-of-pocket costs. (Goldman, 10/9)

A slate of popular policies commonly bandied about to help reduce drug costs would each cut average prices by only a handful of percentage points, according to a recent Congressional Budget Office report. But even small percentage savings could be consequential: By 2031, the retail drug market is slated to grow to more than $690 billion, according to the CBO. That includes both public and private buyers. (Lim and Gardner, 10/8)

The U.S. health regulator has declined to approve Zealand Pharma's (ZELA.CO) drug to prevent and treat low blood sugar in children with a genetic disorder, the Danish biotech firm said on Tuesday, marking the second rejection for the treatment. The Food and Drug Administration (FDA) in its so-called "complete response letter" cited the timing of a third-party manufacturing facility reinspection for the decision, the company said. The letter, however, did not mention any concerns about the clinical data package or safety of the drug, dasiglucagon. (10/9)

Federal authorities are warning of a new ransomware gang that has already claimed at least one healthcare victim in the U.S. Trinity ransomware, which was first detected around May, uses tactics such as phishing emails, malicious websites and software vulnerabilities to hack organizations then employs "double extortion," according to an Oct. 4 notice from HHS' Office of Information Security and Health Sector Cybersecurity Coordination Center. (Bruce, 10/8)

Providers, health IT groups and reproductive health care advocates largely support a proposed HHS rule to make health data, including public health information, easier to share while protecting patient privacy. But they disagree on the specific wording needed to protect reproductive health care data. Background: The rule, proposed in July, would standardize how public health departments transmit data among each other and to the CDC via certified protocols. (Cirruzzo and Leonard, 10/8)

Â鶹ŮÓÅ Health News: Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention Of Lawmakers

It sounds like a joke: poppy seeds infused with opioids. Indeed, it was a plotline on the sitcom Seinfeld. But for some it has been a tragedy. People have died after drinking tea brewed from unwashed poppy seeds. And after eating lemon poppy seed bread or an everything bagel, mothers reportedly have been separated from newborns because the women failed drug tests. Poppy seeds come from the plant that produces opium and from which narcotics such as morphine and codeine are derived. (Hilzenrath, 10/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ